| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |